Stock GTAB B GLYCOREX TRANSPLANTATION AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Glycorex Transplantation AB

Equities

GTAB B

SE0000524530

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.912 SEK -14.77% Intraday chart for Glycorex Transplantation AB -0.87% -31.17%
Feb. 28 Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 28 Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 153 136.3 726.5 849.3 686.8 302.8
Enterprise Value (EV) 1 144.3 122.2 725.2 809.4 653.8 279.3
P/E ratio -9.65 x 47.8 x 105 x -105 x -56.1 x -35.3 x
Yield - - - - - -
Capitalization / Revenue 4.37 x 3.6 x 18.4 x 29.7 x 23.7 x 8.1 x
EV / Revenue 4.12 x 3.23 x 18.3 x 28.3 x 22.5 x 7.47 x
EV / EBITDA -267 x 34.1 x 93.3 x -118 x -57 x -35.6 x
EV / FCF -239 x -35.5 x 229 x 416 x 2,610 x -479 x
FCF Yield -0.42% -2.82% 0.44% 0.24% 0.04% -0.21%
Price to Book 3.35 x 2.54 x 11.5 x 8.92 x 8.28 x 4.07 x
Nbr of stocks (in thousands) 66,509 66,509 69,854 73,854 73,854 73,854
Reference price 2 2.300 2.050 10.40 11.50 9.300 4.100
Announcement Date 4/27/18 4/30/19 4/30/20 4/21/21 11/29/22 4/28/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 35.01 37.82 39.58 28.64 29.01 37.39
EBITDA 1 -0.54 3.587 7.776 -6.885 -11.46 -7.836
EBIT 1 -1.563 2.753 7.444 -7.153 -11.82 -8.358
Operating Margin -4.46% 7.28% 18.81% -24.98% -40.73% -22.35%
Earnings before Tax (EBT) 1 -15.88 2.793 6.876 -8.05 -12.24 -8.52
Net income 1 -15.85 2.861 6.906 -8.04 -12.24 -8.576
Net margin -45.27% 7.56% 17.45% -28.07% -42.2% -22.94%
EPS 2 -0.2383 0.0429 0.0989 -0.1093 -0.1658 -0.1161
Free Cash Flow 1 -0.6051 -3.445 3.171 1.946 0.2505 -0.5831
FCF margin -1.73% -9.11% 8.01% 6.79% 0.86% -1.56%
FCF Conversion (EBITDA) - - 40.78% - - -
FCF Conversion (Net income) - - 45.92% - - -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/30/19 4/30/20 4/21/21 11/29/22 4/28/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 8.64 14.2 1.27 40 33.1 23.5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.61 -3.45 3.17 1.95 0.25 -0.58
ROE (net income / shareholders' equity) -29.6% 5.6% 11.5% -10.1% -13.7% -10.9%
ROA (Net income/ Total Assets) -1.55% 2.83% 6.09% -4.5% -6.89% -5.28%
Assets 1 1,021 101.2 113.4 178.5 177.8 162.4
Book Value Per Share 2 0.6900 0.8100 0.9100 1.290 1.120 1.010
Cash Flow per Share 2 0.1200 0.1900 0.2100 0.6500 0.5600 0.4400
Capex 1 0.02 - 0.13 0.37 1.87 0.86
Capex / Sales 0.04% - 0.32% 1.31% 6.43% 2.3%
Announcement Date 4/27/18 4/30/19 4/30/20 4/21/21 11/29/22 4/28/23
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Supplies

1st Jan change Capi.
GLYCOREX TRANSPLANTATION AB Stock Glycorex Transplantation AB
-31.17% 6.14M
COLOPLAST A/S Stock Coloplast A/S
+11.63% 27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-31.67% 2.98B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-14.68% 2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+11.64% 2.34B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+2.96% 1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-11.65% 1.83B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-1.67% 1.39B
NAKANISHI INC. Stock Nakanishi Inc.
-0.38% 1.27B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+3.58% 1.13B
Medical Supplies
  1. Stock Market
  2. Equities
  3. GTAB B Stock
  4. Financials Glycorex Transplantation AB